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Abstract
The phagocytic receptor for unopsonized Pseudomohas aerugi-
nosa was characterized functionally using human monocyte-de-
rived macrophages. Freshly isolated human peripheral blood
monocytes were unable to ingest unopsonized P. aeruginosa,
ingestion did not occur until the cells had been in culture for 2 d
and it became maximal after 4 d. Macrophages plated on cov-
erslips derivatized with anti-BSA IgG or with human gamma-
globulin lost the cipacity to phagocytose unopsonized P. aeru-
ginosa, unopsonized zymosan, and EIgG but bound C3bi-
coated erythrocytes normally. Each of the four human IgG
subclasses and Fc fragments of anti-BSA IgG inhibited phago-
cytosis of both unopsonized P. aeruginosa and EIgG. Phagocy-
tosis ofP. aeruginosa and zymosan was markedly impaired and
EIgG minimally inhibited if macrophages were plated on cov-
erslips derivatized with mannan or when mannan was added to
the phagocytosis buffer. Phagocytosis of P. aeruiginosa and
zymosan, and binding of EC3bi was dependent on the presence
of divalent cations, but phagocytosis of EIgG was not. The
macrophage phagocytic receptor for unopsonized P. aerui-
nosa was inactivated by proteolytic enzymes. Phagocytosis of
P. aerugnosa was inhibited by D-mannose, L-fucose, and a
methyl mannoside, but not by L-mannose, D-fucose, or D-glu-
cose. The same sugars inhibited phagocytosis of unopsonized
zymosan. We conclude that phagocytosis of unopsonized P.
aeruginosa by human monocyte-derived macrophages is facili-
tated by mannose receptors.
Introduction
Although most pathogenic microorganisms require opsoniza-
tion for efficient phagocytosis, certain bacteria, fungi, and par-
asites are recognized by macrophages or neutrophils in the
absence ofan exogenous source ofcomplement or Ig (1, 2). We
have observed previously that certain nonmucoid strains of
Pseudomonas aeruginosa from patients with cystic fibrosis
(CF)' are phagocytosed by human neutrophils (PMN), mono-
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1. Abbreviations used in this paper: aMM, alpha methyl D-mannopyr-
anoside; CF, cystic fibrosis; EC3bi, erythrocytes opsonized with C3bi;
EIgG, erythrocytes opsonized with IgG; Es", sheep erythrocytes;GVB,
veronal buffer with 0.1% gelatin; MFR, mannosyl, fucosyl receptors;
MO, monocyte-denrved macrophages.
cyte-derived macrophages (MO), and pulmonary alveolar mac-
rophages in the absence of serum (3, 4). This process appears
to be facilitated by bacterial piliation and hydrophobicity and
is abrogated by the exopolysaccharide ofmucoid strains (4, 5).
Nonopsonic phagocytosis of P. aeruginosa by human PMN is
inhibited by D-mannose and mannose-containing saccharides
(3). Phagocytosis of zymosan by human macrophages is also
mannose inhibitable and appears to be mediated predomi-
nantly by mannosyl, fucosyl receptors (MFR) (6).
The process of nonopsonic phagocytosis of P. aeruginosa
may be of critical importance in the natural defense ofthe lung
early in the course of infection. Before the evolution of an
inflammatory response, there may be insufficient quantities of
opsonins to permit phagocytosis by Fc or complement recep-
tors, and nonopsonic receptor-mediated phagocytosis may
play a key role in pulmonary antisepsis. In CF patients, P.
aeruginosa colonizes and proliferates in the respiratory tract
despite the presence of anti-pseudomonal Ig. In fact anti-
pseudomonal IgG from some patients with CF inhibits phago-
cytosis of P. aeruginosa by macrophages (7, 8). Serum from
some patients with CF may fail to promote phagocytosis and
the killing ofP. aeruginosa because ofthe epitope-specificity of
the Igs (9). The purpose of this study was to characterize mac-
rophage phagocytic receptors for unopsonized P. aeruginosa
in order to better understand the process ofnormal pulmonary
host defense against this organism and to gain insights into the
pathophysiology of lung infections in patients with CF.
Methods
Reagents. Mouse MAbs against macrophage surface antigens were as
follows: IB4 (IgG2a, anti-beta chain of the C3bi receptor, LFA-1,
p150,95 family) (10); OKMl (IgG2a, anti-alpha chain C3bi receptor)
(10); anti-Leu M5 (IgG2b, anti-alpha chain p15O,95, Becton Dickin-
son & Co., Mountain View, CA) (1 1); anti-CRI (IgGil, anti-C3b re-
ceptor, Becton Dickinson); Leu-15 (IgG2a, anti-C3bi receptor, Becton
Dickinson); and 3G8 (IgG l, anti-Fc receptor ofneutrophils and mono-
cytes (12), kindly provided by Dr. Jay Unkeless, Mount Sinai Medical
School, NY).
Rabbit anti-BSA was purchased from Cappel Biomedical, Inc.
(Malvern, PA). Human Ig for intravenous use, pH 4.0 (Sand globulin)
from Sandoz Canada Inc., contained > 90% monomeric IgG and all
four human IgG subclasses. Human IgG subclasses were kindly pro-
vided by Dr. F. Skvaril, Institute for Cancer Research, Berne, Switzer-
land.
Mannan from Saccharomyces cerevisiae, n-mannose, L-mannose,
alpha methyl D-mannopyranoside (aMM), D-fucose, L-ftfcose, and D-
glucose were purchased from Sigma Chemical Co. (St. Louis, MO).
Preparation ofFcfragments. Rabbit anti-BSA (6 mg/mi in 0.02 M
PBS, pH 7.3) was incubated with 60 pg/ml papain (Sigma) in 0.01 M
cysteine and 0.002 M EDTA (Sigma) for 4 h at 37°C. After overnight
dialysis in 0.005 M Tris-HCl, pH 8.0, the digestate was separated by
ion-exchange using HPLC (Waters Associates, Milford, MA). Fc frag-
ments formed crystals and were identified by molecular weight on
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12.5% SDS-PAGE and by countercurrent immunoelectrophoresis
using goat anti-rabbit IgG (Sigma). Fab and Fc fragments were readily
distinguished by their characteristic migrations on immunoelectropho-
resis.
Particles for phagocytic assays. P. aeruginosa strain P-I NM is a
spontaneous nonmucoid laboratory revertant of a mucoid strain from
the sputum ofa patient with CF (3). It is a LPS-rough, serum-sensitive,
piliated strain. Bacteria were maintained frozen and grown fresh over-
night on Mueller-Hinton agar for each experiment. Zymosan particles
(Sigma) were prepared exactly as described (6).
Sheep erythrocytes (EP) were purchased from Prepared Media Lab-
oratories (Tualatin, OR) and were opsonized exactly as described pre-
viously (13). Briefly, erythrocytes opsonized with IgG (EIgG) were
prepared by incubating ES with a subagglutinating concentration of
rabbit anti-El IgG (Cordis Laboratories, Inc., Miami, FL) at 370C for
30 min and then at 00C for 30 min. Erythrocytes opsonized with C3bi
(EC3bi) were prepared by incubating EP successively with rabbit anti-
Esl IgM (Cordis), guinea pig C1, C4, C2 (Cordis), and human C3
(Cytotech, San Diego, CA), and finally with diisopropylfluorophos-
phate (Sigma) and human C3 inactivator (Cordis). EIgG were prepared
fresh on the day of each experiment; the EC3bi were used within 2 wk
of preparation.
Macrophage cultivation. Macrophages were derived from human
peripheral blood monocytes by culture in suspension in teflon beakers
as described previously (6). Briefly, mononuclear cells were separated
from heparinized peripheral venous blood on a Ficoll-Hypaque gra-
dient and cultured with 13% autologous fresh human serum at 37°C in
5% CO2. The cells were washed free of serum on the day of each
experiment and plated on glass coverslips. These cells were viable as
determined by trypan blue dye exclusion and by their capacity to
phagocytose opsonized and unopsonized particles.
Preparation of substrate-coated coverslips. Glass coverslips were
derivatized with substrates by a modification of Michl's method (14).
12-mm-diam round glass coverslips were acid-washed and a 5-mm-
diam circle was drawn in the center. The coverslips were placed, circle
side down, in wells of a 24-well plastic tissue culture plate (Falcon
Labware, Becton Dickinson & Co., Oxnard, CA) and 0.5 ml of poly-
L-lysine (mol wt > 70,000, 0.1 mg/ml) was added. After a 30-min
incubation at 24°C, the coverslips were washed and incubated in 2.5%
glutaraldehyde for 15 min at 24°C. The coverslips were then washed
exhaustively, aspirated dry, and 10 jul of the desired protein substrate
was added to the center ofthe circle. After a further 60-min incubation
at 24°C, the coverslips were washed and incubated in PBS with 1.5
g/l00 ml glycine and 1 mg/ml BSA at 4°C overnight to block any
unbound aldehyde sites. Immediately before use, the coverslips were
washed in PBS, pH 7.4. Derivatization with polysaccharides was
achieved using the same method except that 10 mg of I-ethyl-3-di-
methylamino-propyl) carbodiimide was added to 50 mg ofpolysaccha-
ride during the substrate binding step (15).
Assessment ofphagocytosis. Phagocytosis of P. aeruginosa (3), zy-
mosan (6), EIgG, and EC3bi (13) was assessed by visual inspection
exactly as described. In most experiments, M4 were used between 4
and 7 d of in vitro cultivation, at which time they had all the charac-
teristics of macrophages but had not begun to fuse with one another. In
each experiment, 100 cells were examined. Phagocytosis of P. aerugi-
nosa was expressed as the percentage of MO with < 6, 6-19, or > 19
bacteria ingested. Phagocytosis ofzymosan and EIgG was expressed as
the average number of particles ingested by each M4. Results with
EC3bi represented the average number of particles attached to each
M4. All experiments were repeated at least three times on separate
days with MO from different donors. Results are expressed from indi-
vidual experiments but are representative of data from the other days.
Since the phagocytic capacity ofMk from different donors, or from the
same donor on different occasions was so varied, pooling of data was
not attempted.
Enzyme susceptibility ofMO receptors. Macrophages were plated
on glass coverslips in the usual fashion, washed with PBS, and placed in
separate wells of a 24-well tissue culture plate (Falcon). The wells
contained 1 ml of RPMI with 10 mM Hepes (Sigma) and one of the
following enzymes (all purchased from Sigma): 100 and 500 yg/ml
trypsin, 100 ,ug/ml pepsin, 10 and 100Ig/ml protease type IX from
Bacillus polymyxa, 10 and 100 jsg/ml papain, 10 and 100 g/mI neur-
aminidase, 100 ,ug/ml a mannosidase, and 10 yg/ml a galactosidase.
After a 30-min incubation at 370C in 5% C02, the coverslips were
washed thoroughly with PBS and particles for phagocytosis were added
to the wells.
Divalent cation-dependence for phagocytosis of different particles.
Divalent cation-dependence was assessed either by adding Ca2' and/or
Mg2' to cation-free media or by chelating the cations in the medium.
GVB buffer (veronal buffer with 0.1% gelatin) was made with 2 g/liter
BSA and 2.4 g/liter Hepes was added. In some experiments, 0.5 mM
CaCl2 and/or MgCl2 was added to this buffer. MO were washed, sus-
pended in RPMI medium with 0.1% BSA and 10 mM Hepes, and
plated on coverslips. After the MO were plated, the coverslips were
washed extensively in PBS without divalent cations and added to wells
that contained GVB= with or without the divalent cations. Particles
were added and phagocytosis was assessed in the usual manner. For
chelation of divalent cations, 2 mM EDTA or EGTA was added to
RPMI medium with BSA and Hepes. Phagocytosis assays were per-
formed in these solutions with MO that had been plated on coverslips
in RPMI medium with BSA and Hepes.
Electron microscopy. Macrophages were prepared as described
above and plated in wells of a 24-well tissue culture plate (Falcon).
Incubation with P. aeruginosa was conducted in the same way as it was
for assessment of phagocytosis. After a 60-min incubation, the wells
were washed and the contents were fixed with glutaraldehyde, osmium
tetroxide, and graded concentrations of ethanol. The cells were then
embedded in epon, sectioned, and viewed with a Jeol 1200 electron
microscope.
Results
P. aeruginosa strain P-lNM was phagocytosed well by human
monocyte-derived macrophages (4-6 d in culture) in the ab-
sence of exogenous serum opsonins. In contrast, freshly iso-
lated human peripheral blood monocytes were unable to
phagocytose P. aeruginosa; ingestion did not occur until the
cells had been in culture for 2 d and maximal ingestion oc-
curred after 4 d (Fig. 1). Electron microscopy performed on
MO which had been incubated in the presence ofP. aeruginosa
for 1 h at 37°C, revealed many bacteria within phagocytic
vacuoles (Fig. 2A). Bacteria were also seen surrounded by
pseudopods, with the MO membrane in close contact with the
engulfed microorganisms (Fig. 2 B).
When macrophages spread on antibody- or ligand-coated
surfaces, the receptors that bind to these antibodies or ligands
are down-modulated to the adherent surface of the cell (14);
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Table I. Phagocytosis ofP. aeruginosa by Macrophages Plated
on Antibody-coated Coverslips
Phagocytosis*
Substrate <6 6-19 >19
BSA (control) 0 8 92
MAb IB4 (10 jig/ml) 46 40 14
MAb OKMl (20 Ag/ml) 4 24 72
MAb anti-Leu M5 (25 ,ug/ml) 16 16 68
MAb anti-CRi (25 u.tg/ml) 12 15 73
MAbLeu 15 (20 qg/ml) 7 6 87
MAb 3G8 (20 jg/ml) 8 37 55
* Percentage of macrophages with the indicated number of bacteria
ingested.
To determine ifunopsonized P. aeruginosa is phagocytosed by
one of the recognized macrophage membrane receptors, cov-
erslips were derivatized with MAbs directed against the C3bi
receptor (IB4, OKM 1, and Leu 15), the C3b receptor (anti-
CR1), a human PMN and monocyte Fc receptor (3G8), and
the p150,95 antigen (anti-Leu M5). Macrophages were plated
on the derivatized coverslips and then phagocytosis of P. aeru-
ginosa was assessed. For the control, macrophages were plated
on a coverslip derivatized with BSA. This experiment was per-
formed on 18 separate occasions with macrophages (after 4-7
d of in vitro culture) from different donors. Each of the MAbs
inhibited phagocytosis. MAb IB4 (directed against the beta
chain of the C3bi receptor, LFA-l, and p150,95 family of
glycoproteins) consistently exerted the greatest inhibitory ef-
fect. Results of one such experiment are shown in Table I.
These MAbs were bound to the coverslips, presumably in
random orientations, with either the Fab or Fc portions avail-
able to ligate macrophage receptors. Since all of the antibodies
inhibited the phagocytosis of unopsonized P. aeruginosa to
varying degrees, it was possible that they did so via their Fc
domains. Macrophages were therefore plated on coverslips de-
rivatized with rabbit anti-BSA or human gammaglobulin. Nei-
ther of these antibody preparations is directed against macro-
phage membrane antigens; they would therefore be expected
to specifically ligate only Fc receptors. Phagocytosis ofP. aeru-
ginosa and EIgG was inhibited when MO were plated on either
antibody substrate, but binding of EC3bi was unaffected
(Table II). These data suggest that the Fc domain of IgG is
recognized by receptors that bind P. aeruginosa, or that the
receptors that mediate Pseudomonas ingestion co-modulate
with the Fc receptors.
To determine which ofthe human IgG subclasses was most
capable of down-modulating receptors that recognize unop-
sonized P. aeruginosa, MO were plated on coverslips deriva-
tized with a range of concentrations of each of the four sub-
classes. All four human subclasses were able to interfere with
the phagocytosis of both unopsonized P. aeruginosa (Fig. 3 A)
and EIgG (Fig. 3 B). Although the dose-response inhibition
was not markedly different among the subclasses for either of
Table II. Phagocytosis or Binding ofP. aeruginosa
and Opsonized Erythrocytes by Macrophages Plated
on Ig-coated Coverslips
Phagocytosis Binding
Substrate P. aeruginosa* Zymosant EIgGt EC3bi
Control (BSA) 92 6.5 22.8 17.1
Anti-BSA (60 ,ug/ml) 53 3.0 2.0 20.1
Human gammaglobulin
(30 mg/ml) 7 2.7 5.8 18.5
* Percentage of macrophages with > 19 bacteria ingested.
$Average number of particles ingested per macrophage.
§ Average number of particles attached per macrophage.
the two particles, IgG2 was less effective than IgG l, 3, or 4 in
down-modulating Fc receptor activity (Fig. 3 B).
To further confirm a requirement for the Fc domain ofIgG
to down-modulate macrophage receptors for Pseudomonas,
MO were plated on coverslips derivatized with Fc fragments of
anti-BSA IgG. Phagocytosis of both P. aeruginosa and EIgG
was inhibited (Table III). Fc receptors are co-down-modulated
with MFR when murine MO are plated on mannan-coated
surfaces (16). Inhibition of both EIgG and P. aeruginosa
phagocytosis could therefore indicate that they are both phago-
cytosed by the same receptor, that the receptors for the two
particles are associated with one another and are thus co-
down-modulated by a single ligand, or that Fc receptors and
MFR both react with the same ligands.
Expression of MFR by MO is under maturational control
(6); ingestion of zymosan does not occur until the cells have
been in culture for at least 48 h. We observed that the capacity
ofMO to phagocytose P. aeruginosa exhibits a similar matura-
tional dependence. To determine whether Fc receptors exhib-
ited the same maturational characteristics in this phagocytic
system, ingestion ofEIgG by monocytes in culture on days 0-4
was assessed (Table IV). Freshly obtained human peripheral
blood monocytes were able to ingest EIgG, as were cells after
1-4 d of in vitro culture, which confirmed our previous obser-
vation (12). These observations suggest that the MFR, not Fc
receptors, recognize unopsonized P. aeruginosa.
To determine the role of MFR in the phagocytosis of un-
opsonized P. aeruginosa, MO were plated on coverslips that
had been derivatized with mannan (a mannose-containing oli-
gosaccharide with a potent capacity to ligate MFR). Phagocy-
tosis of P. aeruginosa and zymosan was impaired markedly
after MO were plated on mannan-coated coverslips but EIgG
ingestion was inhibited only marginally. We observed a similar
inhibition pattern ofphagocytosis ofthose three particles when
mannan was added to the phagocytosis buffer (Table V).
Phagocytosis of P. aeruginosa and zymosan was reduced in
proportion to the concentration ofmannan in the medium. In
contrast, uptake of EIgG was reduced by about the same
amount (30-40%) regardless of the concentration of mannan
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Figure 2. Electron micrographs of 5-d-old monocyte-derived macrophages incubated in the presence of unopsonized Pseudomonas aeruginosa
for 1 h. (A) Bacteria in phagocytic vacuoles both within pseudopodia and perinuclear cytoplasm. (B) The macrophage membrane tightly affixed
to a bacterium in an early stage of phagocytosis.
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Figure 3. The effect of human IgG subclasses on phagocytosis of unopsonized Pseudomonas aeruginosa (A) and EIgG (B). Human monocyte-
derived macrophages were plated on coverslips that were derivatized with different concentrations of each IgG subclass and phagocytosis was
assessed (see Methods for details).
used. EIgG are phagocytosed by macrophage Fc receptors (1,
2) and zymosan by macrophage MFR (6) with the cooperation
ofCR3 (17). It appears, therefore, that IgG caused down-mod-
ulation of Fc receptors and MFR, and that mannan caused
only modest impairment of Fc receptor function but pro-
foundly inhibited MFR function. Further experiments were
necessary to determine which of these two receptors might
mediate P. aeruginosa uptake since both mannan and IgG
inhibited its phagocytosis.
Each macrophage phagocytic receptor has characteristic
functional requirements for divalent cations. Receptors for
EC3bi and mannose require Ca2' and/or Mg2', but receptors
for the Fc domain ofIgG mediate binding and phagocytosis of
particles in a divalent cation-free system (1, 15, 18). Macro-
phage divalent cation-dependence for phagocytosis of P. aeru-
ginosa was assessed by modifying the Ca2' and/or Mg2e con-
tent ofthe medium (Table VI). Divalent cations were chelated
by adding EDTA or EGTA to the RPMI medium. Phagocyto-
sis ofP. aeruginosa, EIgG, and zymosan, and binding ofEC3bi
occurred normally in RPMI medium that contained both Ca2+
and Mg2+. Phagocytosis of P. aeruginosa and of zymosan and
binding of EC3bi was inhibited by chelation of divalent cat-
ions. Only EIgG was ingested in GVB= (which is devoid of
divalent cations), confirming that Fc receptors remain func-
tional in the absence ofdivalent cations. Phagocytosis (P. aeru-
ginosa and zymosan) or attachment (EC3bi) were enhanced
when Ca2' and Mg2' were added to GVB=. Phagocytosis and/
or attachment of all four particles was better in RPMI medium
Table III. Phagocytosis ofP. aeruginosa and EIgG
by Macrophages Plated on Fc Fragment-coated Coverslips
Phagocytosis
P. aeruginosa*
Substrate <6 6-19 >19 EIgG$
Control (BSA) 6 48 46 7.7
Anti-BSA (0.6 mg/ml) 57 42 1 0.1
Fc fragments of anti-BSA 46 49 5 0.7
* Percentage of macrophages with indicated number of bacteria in-
gested.
$ Average number of particles ingested per macrophage.
than in GVB with divalent cations added. These data con-
firmed that receptors for EC3bi and zymosan were divalent
cation-dependent, but that Fc receptors were not. They also
showed that the receptors that mediated P. aeruginosa uptake
resemble the C3bi receptor and MFR in their cation depen-
dence.
The macrophage receptors for phagocytosis of unopson-
ized P. aeruginosa were further characterized by assessing their
sensitivity to inactivation by different enzymes (Table VII).
Treatment of macrophages with the proteolytic enzymes,
trypsin, protease, and papain, inhibited phagocytosis of unop-
sonized P. aeruginosa. Phagocytosis was unaffected when
macrophages were pretreated with a galactosidase, a manno-
sidase, pepsin, or neuraminidase. The receptors for binding of
EC3bi and for phagocytosis ofzymosan were also trypsin sen-
sitive, but Fc receptors were not.
Finally, we assessed the ability of soluble monosaccharides
to inhibit uptake of P. aeruginosa (Table VIII). D-mannose,
L-fucose, and aMM were inhibitory, whereas L-mannose, D-
fucose, and D-glucose were not. The same pattern ofinhibition
was seen for zymosan, a particle which, under the conditions
employed in these studies, is phagocytosed predominantly by
MFR (6). These data strongly suggest that the MFR or a simi-
lar receptor mediates uptake of unopsonized P. aeruginosa.
Discussion
Macrophage phagocytic receptors for both opsonized and un-
opsonized particles have been characterized previously (1, 2).
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Table V. The Effect ofMannan on Phagocytosis ofP. aeruginosa,
EIgG, and Zymosan by Macrophages
Phagocytosis
P. aeruginosa*
Condition <6 6-19 >19 EIgG* Zymosant
Control1 15 66 19 9.3 3.9
Mannan (10 mg/mi)" 81 19 0 4.2 0.2
Mannan (1 mg/m)"l 64 36 0 5.8 0.3
Mannan (100 pg/ml)11 13 74 13 5.4 0.8
Mannan, derivatized' 56 42 2 6.8 1.2
* Percentage of macrophages with the indicated number of bacteria
ingested.
tAverage number of particles ingested per macrophage.
§ Macrophages plated on coverslip derivatized with 10 mg/ml BSA.
'Mannan added to phagocytosis medium at indicated final concen-
tration.
' Macrophages plated on coverslip derivatized with 50 mg/ml mannan.
In this paper, we have described the functional characteristics
of human macrophage receptors for phagocytosis of unopson-
ized P. aeruginosa. Although P. aeruginosa is also phagocy-
tosed nonopsonically by human PMN (3), pulmonary alveolar
macrophages (5), and mouse peritoneal macrophages (Speert
and Silverstein, unpublished observations), the studies re-
ported here are confined to human monocyte-derived macro-
phages.
The macrophage receptors for mannose-type oligosaccha-
rides and the macrophage surface molecules that mediate the
uptake of unopsonized P. aeruginosa share several functional
characteristics (Table IX). Both receptors are under matura-
tional control; they are absent from peripheral blood mono-
cytes (19) and do not become functionally competent until
after at least 48 h of in vitro cultivation (6). Phagocytosis me-
diated by both receptors is inhibited in the presence of man-
nose (6), and both are down-modulated when macrophages
are allowed to spread on surfaces derivatized with mannan or
with IgG. Finally, both receptors are divalent cation-depen-
dent, trypsin-sensitive and capable of promoting phagocytosis
in the absence of phorbol esters or fibronectin if the macro-
phages mature in suspension in teflon vessels (15). These
characteristics clearly differentiate between unopsonized P. ae-
ruginosa 's receptors, those ofC3bi, and those ofthe Fc portion
of IgG (1, 2).
We found that macrophages plated on IgG-coated surfaces
lost the capacity to phagocytose via both Fc receptors, and
MFR (Table II). P. aeruginosa phagocytosis was impaired
when macrophages were allowed to spread on either mannan
(Table V) or IgG-coated (Table II) surfaces. A satisfactory ex-
planation for this phenomenon of co-down-modulation has
not yet been provided. Nose and Wigzell (20) reported that
IgG, which was depleted of asparagine-linked carbohydrates,
lost the capacity to interact with macrophage Fc receptors. It is
therefore possible that carbohydrates on IgG are of critical
importance in the ligation of both Fc receptors and MFR.
In addition to their role in the phagocytosis ofglycosylated
macromolecules (21), MFRs play a key role in the ingestion of
unopsonized zymosan (6, 15). Udder the conditions described
in this paper, unopsonized zymosan is phagocytosed by mac-
rophages (6), but not by peripheral blood monocytes (6) or by
unstimulated PMNs (unpublished observation); of these three
types of human phagocytic cells, only macrophages possess
MFR (19). Serum opsonin-independent phagocytosis of cer-
tain gram-negative bacterial species by PMNs is inhibited by
mannose (3, 22-25). In these situations, the inhibitory effects
ofmannose are correlated with the presence ofmannose-bind-
ing adhesins on Escherichia coli (25) and with hydrophobic
pili on P. aeruginosa (4). It is possible that both E. coli and P.
aeruginosa possess mannose-specific lectins on their outer
membranes that interact with neutrophil carbohydrate resi-
dues. The presence of such a lectin-carbohydrate interaction
has been proposed (27, 28). Recently, three human neutrophil
membrane glycoproteins with molecular masses of 70-80 and
150 kD have been shown to bind type 1 E. coli pili in a man-
nose-sensitive fashion (29). Thus the mannose-sensitive
phagocytosis of bacteria by neutrophils may involve bacterial
lectins; conversely, mannose-sensitive phagocytosis ofbacteria
by macrophages appears to involve lectin-like receptors and
bacterial carbohydrates. It is possible that mannose-sensitive
phagocytosis ofbacteria by macrophages may involve two sep-
arate receptor-ligand interactions which are mediated by either
bacterial or macrophage lectins. The P. aeruginosa strain stud-
ied by us has surface-exposed mannose residues (mannose-
sensitive agglutination by Con A) but it lacks madnose-sensi-
tive lectin activity (inability to agglutinate human red blood
cells) (unpublished observation). The mannose-sensitive
Table VI. The Effect ofDivalent Cations on Phagocytosis ofDifferent Particles
Phagocytosis
P. aeruginosa* Binding
Condition <6 6-19 >19 EIgGt Zymosant EC3bit
Control (RPMI with Ca2l and Mg2") 16 64 20 8.8 6.5 4.6
RPMI + EGTA (2 mM) 71 29 0 8.9 0.9 0.3
RPMI + EDTA (2 mM) 97 3 0 6.3 0.6 0.8
GVB (divalent cation-free) 97 3 0 6.9 0.1 0.0
GVB + Mg2+ (0.5 mM) 86 14 0 6.3 1.2 3.6
GVB + Ca2+ (0.S mM) 70 30 0 6.4 1.9 1.9
GVB- + Mg2+ + Ca2+ 71 28 1 5.7 2.4 4.7
* Percentage of macrophages with the indicated number of bacteria ingested. $ Average number of particles per macrophage.
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Table VII. The Effect ofEnzyme Treatment ofMacrophages on Phagocytosis or Binding ofDifferent Particles
Phagocytosis
P. aeruginosa Binding
Condition <6 6-19 >19 EIgGK Zymosant EC3biO
Control 1 22 77 9.8 4.8 6.4
a Galactosidase (10 ug/ml) 0 17 83 7.6 4.7
a Mannosidase (100 yg/ml) 3 23 74 11.2 4.8
Trypsin (100 jg/ml) 22 57 21 11.9 0.6 1.0
Trypsin (500 Ag/ml) 40 47 13 8.5 0.1
Pepsin (100 jsg/ml) 1 16 83 8.6 3.0
Protease (10 gg/ml) 5 25 70 8.4 2.3
Protease (100 gg/ml) 20 57 23 10.4 0.3
Neuraminidase (10 Ag/ml) 8 26 66 15.9 4.5
Neuraminidase (100 Ag/ml) 3 31 66 15.5 3.5
Papain (10 ug/ml) 23 45 32 12.9 3.1
Papain (100 jg/ml) 30 50 20 18.2 3.1
* Percentage of macrophages with indicated number of bacteria ingested. Average number of particles per macrophage.
phagocytosis of P. aeruginosa by macrophages is therefore
most likely mediated by macrophage rather than by bacterial
lectins.
While our studies show that the MFR is necessary for the
recognition ofunopsonized P. aeruginosa, they do not rule out
the participation of other,MO receptors. Other microbes (His-
toplasma capsulatum (30) and E. coli (18) have been shown to
be recognized nonopsonically by the LFA-1, CR3, p150,95
family ofadhesion-promoting glycoprotein receptors; our data
suggest that these receptors may also participate in the recogni-
tion of P. aeruginosa. There was marked inhibition ofPseudo-
monas phagocytosis when MO were plated on surfaces coated
with MAb 1B4, which recognizes all three members of this
glycoprotein family (Table I). Since the inhibition caused by
IB4 was far greater than that caused by other IgGs, it is un-
likely that the Fc domain ofIB4 accounts for all the inhibition.
Rather, down-modulation of LFA-1, CR3, and p150,95 may
Table VIII. The Effect ofDifferent Sugars on Phagocytosis
ofP. aeruginosa and Zymosan by Macrophages
Phagocytosis
P. aeruginosat
Sugar* <6 6-19 >19 Zymosan
Control 10 52 38 7.71
D-mannose 19 67 13 1.82
L-mannose 20 42 38 6.04
D-fucose 16 63 22 5.15
L-fucose 40 52 8 2.12
aMM 34 58 8 1.79
D-glucose 12 61 27 5.62
* All sugars were used at a final concentration of 10 mg/ml and were
present during the phagocytosis assay.
Percentage of macrophages with the indicated number of bacteria
ingested.
§ Average number of particles ingested per macrophage.
decrease phagocytosis of P. aeruginosa by removing receptors
that function in cooperation with the MFR. Other investiga-
tors (17) have demonstrated that CR3 has lectin-like properties
and is capable of mediating ingestion of unopsonized zymo-
san. They further described two separate epitopes of CR3, one
that mediates binding of C3bi-coated particles and another
that mediates ingestion of zymosan. CR3 could therefore me-
diate phagocytosis of unopsonized P. aeruginosa by interact-
ing with bacterial surface-exposed glycoconjugates. Ingestion
but not attachment of C3bi-coated particles by CR3 is under
maturational control, first occurring after the cells have been
in culture for more than 48 h (31). This further suggests a role
for CR3 in the recognition of unopsonized P. aeruginosa,
phagocytosis of which was not observed until monocytes had
been in cultures for at least 48 h.
Nonopsonic phagocytosis ofP. aeruginosa by human mac-
rophages may play an important role in normal host defense of
the lung. Macrophages are part of the first line of lung defense
and must often function in a milieu where there are low levels
ofboth complement and Igs; phagocytosis ofsome strains ofP.
aeruginosa by macrophages is, in fact, inhibited by serum (7,
Table IX. Characteristics ofDifferent Phagocytic Receptors
on Monocyte-Derived Macrophages
Receptor
Characteristic FcR CR3 Mannose Pseudomonas
Appears during in vitro
maturation No No Yes > 3 d Yes 2 2 d
Inhibited by mannan in
suspension Yes ND Yes Yes
Down-modulated by
mannan Yes ND Yes Yes
Divalent cation
dependent No Yes Yes Yes
Trypsin sensitive No Yes Yes Yes
Down-modulated by IgG Yes No Yes Yes
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8, and Speert and Thorson, unpublished observation). Sub-
version of this nonopsonic phagocytic process by bacterial or
host products might then permit a relatively avirulent micro-
organism to gain ascendancy in the bronchopulmonary tract
and to cause disease. P. aeruginosa exoproducts (such as the
mucoid exopolysaccharide) or shed cell membrane structures
(such as LPS) might compete for the pulmonary alveolar mac-
rophage receptor for unopsonized Pseudomonas. Such may be
the case in patients with CF since chronic bronchopulmonary
infection is a hallmark of the disease (32) and bacteria in very
high density are characteristically present in bronchopulmo-
nary secretions.
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